InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2026-05-21 17:13:14 ET · period of report 2026-05-20 · accession 0001804442-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-21 17:13 2026-05-20 TDOC Jacobson Catherine Dir M - OptEx — +29.0K 66.9K +77% —
D 2026-05-21 17:13 2026-05-20 TDOC Jacobson Catherine Dir M - OptEx $0.00 -29.0K 0 -100% $0
D 2026-05-21 17:13 2026-05-21 TDOC Jacobson Catherine Dir A - Grant $0.00 +30.4K 30.4K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-20 M A 28,986 — 66,853 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Derivative Restricted Stock Units 2026-05-20 M D 28,986 $0.00 0 D — · — to — 28,986 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F2) On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. (F2) On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026.
3 Derivative Restricted Stock Units 2026-05-21 A A 30,441 $0.00 30,441 D — · — to — 30,441 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F4) The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. (F4) The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders.